Furthermore, recognising the role of PALB2 in the DNA repair pathway is increasingly important, particularly as updated treatment guidelines now recommend assessing this gene when deciding whether patients with breast or pancreatic cancer may benefit from PARP inhibitor therapy (8). Here, PALB2 is linked to pancreatic neoplasm.